Aditxt, Inc. (ADTX)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.00
- As of
Kresmion compiles this page from ADTX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Aditxt, Inc. (ADTX): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-15.
See the full ADTX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ADTX on one page. Preview it with sample data, then open it live with a free account.
Preview the ADTX dossierActive events for ADTX
No recent events on ADTX in the last 180 days.
FREE, NO ACCOUNT
Every event on ADTX, as it fires
New filings, 13F moves and cross asset events on ADTX land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, ADTX
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
ADTX's 10-Q filed May 20, 2026 states:
We believe our remaining funds on hand will not be sufficient to fund our operations for the next 12 months and such creates substantial doubt about our ability to continue as a going concern beyond one year.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on ADTX
ADTX against its peers
ADTX's operating margin of -612542.2% ranks in the 5th percentile of 10 Biotechnology sub-industry peers, fiscal periods ending between 2025-03-31 and 2026-06-30.
| Metric | ADTX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 3195 USD | 1.4M USD | 14 | 10 |
| Gross margin | 8.4% | 55.1% | 42 | 5 |
| Operating margin | -612542.2% | -722.3% | 5 | 10 |
| Net margin | -1349028.2% | -748.0% | 5 | 10 |
| Return on equity | -768.3% | -106.4% | 5 | 9 |
Peers (18): CDT, EVFM, LNAI, CPMV, PTIX, ARTL, VRAX, VBIO, SCNI, MTNB, RMTG, ISCO, BDRX, AGTX, ATXI, LYRA, OGEN, GOVX. Left out: MLEC (period gap), LABT (no annual filing), AXIM (period gap), BBLG (no annual filing), CYTOF (period gap), CLSDQ.D (no annual filing), ELAB (no annual filing). Fiscal periods ending between 2025-03-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (ADTX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in ADTX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on ADTX in the last 180 days.
Upstream: SEC EDGAR filings for ADTX
Kresmion, "Aditxt, Inc. (ADTX) institutional holdings and SEC filings", data as of 2026-10-15, https://kresmion.com/research/ADTX. Upstream data: SEC EDGAR filings for ADTX.
Link to this data (HTML):
<a href="https://kresmion.com/research/ADTX">Aditxt, Inc. (ADTX) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow ADTX on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to ADTX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.